CV Disease in Special Populations

View all - Anticoagulation Antiplatelet DOAC

View all - Demographic Age Gender Ethnicity

View all - Heterogeneous Populations Inherited and Congenital Cardiac Conditions Congenital Heart Disease

View all - Vascular Disease and Surgery Aortic Disease - General Carotid Artery Disease Stroke Peripheral Artery Disease - General Occlusive Venous Disease - General Pulmonary Embolism Deep Vascular Intervention Endovascular Techniques

View all - Standards & Guidelines

View all - Imaging & Diagnostics Angiography CT/MRI Echocardiography & Ultrasound Nuclear

View all - Heart Failure Amyloidosis Paediatric Heart Failure Imaging and Diagnosis Devices Co-morbidities Cardiomyopathy Advancement in Heart Failure

View all - Electrophysiology & Arrhythmia Ventricular Arrhythmias Supraventricular Tachycardia Stroke Prevention in Atrial Fibrillation Reversal Agents Pacing, Defibrillators & Cardiac Resynchronisation Therapy Catheter Ablation of Cardiac Arrhythmias Real World Contact Force Ablation Persistent Atrial Fibrillation Using Arctic Front™ Cardiac Cryoablation System Atrial Fibrillation Atrial Arrhythmias Sudden Cardiac Death

View all - Digital Health

View all - COVID-19

View all - Prevention & Chronic Conditions Angina Cardiac Rehabilitation Programmes Chronic Kidney Disease Coronary Artery Disease and Myocardial Infarction Atherosclerosis and Hyperlipidemia Diabetes Hypertension Hypertension Management Pulmonary Arterial Hypertension Lifestyle Nonalcoholic Steatohepatitis (NASH) Obesity Stroke

View all - Pericardium Disorders

View all - MI/ACS Unstable Angina & NSTEMI STEMI

View all - Intervention Drug-eluting balloons Structural Intervention Peripheral Intervention Coronary Interventions Transradial Intervention Intravascular Imaging Coronary Physiology Bifurcation

View all - CV Disease in Special Populations Cardio-oncology Amyloidosis Cardiotoxicity Clinical Practice

CV Disease in Special Populations

Most Recent Most Viewed

Topics

Video Series

CV Disease in Special Populations

Diversity in Cardiovascular Disease

Martha Gulati,

Broadcast

Electrophysiology & Arrhythmia

COVID-19

POTS-associated Conditions and Management Strategies

Alexis Cutchins, Svetlana Blitshteyn, Rebecca Steinberg, et al

Watch time: 14s

ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Video

Heart Failure

Prevention & Chronic Conditions

ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi,

Watch time: 23m 6s

ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT

Video

CV Disease in Special Populations

ACC.24: The PROACT Trial

David Austin,

Watch time: 3m 37s

Video

Anticoagulation

Vascular Disease and Surgery

ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s

Article

Imaging & Diagnostics

CV Disease in Special Populations

A Case of Primary Cardiac B-cell Lymphoma Diagnosed with Cardiac MRI

Kevin Lee , Iva Minga , Eryn Cameron , et al

Read time: 8m

Broadcast

CV Disease in Special Populations

Ibrutinib Is Associated With Increased Cardiovascular Events and Major…

Daniel Lenihan, , , et al

Watch time: 53m 54s

Broadcast

CV Disease in Special Populations

Addressing Disparities in Cardio-Oncology

Daniel Lenihan, , , et al

Watch time: 58m 27s

Broadcast

CV Disease in Special Populations

Cardiotoxicity in Breast Cancer: Challenges of Multimodal Therapies

Daniel Lenihan, , , et al

Watch time: 1h 7m 36s

Broadcast

CV Disease in Special Populations

Practical Cardiovascular Principles of Cancer Survivorship

Daniel Lenihan, ,

Watch time: 1h 1m 32s

ACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial

Video

Heart Failure

Prevention & Chronic Conditions

ACC 23: The STOP-CA Trial

Marielle Scherrer-Crosbie,

Watch time: 5m 59s

Video

Heart Failure

Prevention & Chronic Conditions

ACC 23: The LIVE-HCM Trial

Rachel Lampert, Michael Ackerman, Sharlene Day, et al

Watch time: 6m 25s

Article

Demographic

Prevention & Chronic Conditions

Menopause, Cholesterol and Cardiovascular Disease

Heather Currie , Christine Williams ,

Read time: 10m

Article

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions

Identification of Patients at Risk of Stroke From Atrial Fibrillation

Raymond B Fohtung , Michael W Rich ,

Article

Prevention & Chronic Conditions

Heterogeneous Populations

Management of Patent Foramen Ovale

Kimberly Atianzar , Peter Casterella , Ming Zhang , et al

Article

Intervention

Heterogeneous Populations

Non-surgical Alternatives in the Treatment of Congenital Heart Defects

William E Hellenbrand ,

Article

Vascular Disease and Surgery

Electrophysiology & Arrhythmia

Essentials in the Post-operative Evaluation of Congenital Heart Disease

Jonathan N Johnson , Frank Cetta ,

Video Series

Anticoagulation

Standards & Guidelines

ESC 22: Late-breaking Science Collection

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Article

Prevention & Chronic Conditions

Demographic

A Review of the Antihypertensive and Renal-protective Effects of Irbesartan

Keith C Ferdinand ,

Video Series

Anticoagulation

Standards & Guidelines

ESC 2021: Late-breaking Science Video Collection

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Article

Heterogeneous Populations

Single-Ventricle Physiology

Lydia Taranto , Tabitha Moe ,

Article

Heart Failure

Prevention & Chronic Conditions

Impact of Atrial Septal Defect on Hemodynamics

Saumil R Shah , Sergio Waxman , William H Gaasch ,

Article

Heterogeneous Populations

Coarctation: A Review

Marc G Cribbs ,

Article

Demographic

Prevention & Chronic Conditions

Do We Need a Different Approach to Assess Cardiovascular Risk in Women?

Ijeoma Isiadinso , Nanette K Wenger ,

Read time: 15m

Media

Broadcast

CV Disease in Special Populations

Ibrutinib Is Associated With Increased Cardiovascular Events and Major…

Daniel Lenihan, , , et al

Watch time: 53m 54s

Broadcast

CV Disease in Special Populations

Addressing Disparities in Cardio-Oncology

Daniel Lenihan, , , et al

Watch time: 58m 27s

Broadcast

CV Disease in Special Populations

Cardiotoxicity in Breast Cancer: Challenges of Multimodal Therapies

Daniel Lenihan, , , et al

Watch time: 1h 7m 36s

Broadcast

CV Disease in Special Populations

Practical Cardiovascular Principles of Cancer Survivorship

Daniel Lenihan, ,

Watch time: 1h 1m 32s

Video

Heart Failure

Prevention & Chronic Conditions

ACC 23: The STOP-CA Trial

Marielle Scherrer-Crosbie,

Watch time: 5m 59s

Broadcast

Anticoagulation

Vascular Disease and Surgery

Radcliffe Premiere TV: ESC 2022

Watch time: 3h 52m 31s

Video Series

Demographic

Electrophysiology & Arrhythmia

Cardio-oncology A-Z

Neha Bansal, Joshua Mitchell, Avirup Guha, et al

Watch time: 56m 19s (7 videos)

Cardio-oncology A-Z: Late Effects Cardiotoxicity

Video

CV Disease in Special Populations

Cardio-oncology A-Z: Late Effects Cardiotoxicity

Neha Bansal,

Watch time: 8m 22s

SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Video

Prevention & Chronic Conditions

SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients

Rafael Romaguera,

Watch time: 8m 19s

GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups

Video

Heart Failure

CV Disease in Special Populations

GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic…

David Lanfear,

Watch time: 5m 27s

Introduction to CV Health Concerns Among LGBTQ+ Populations

Video

Demographic

Standards & Guidelines

Introduction to CV Health Concerns Among LGBTQ+ Populations

Billy A Caceres, Carl Streed,

Watch time: 29m 19s

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Video

Standards & Guidelines

Imaging & Diagnostics

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 36m 1s

Media

Video Series

CV Disease in Special Populations

Diversity in Cardiovascular Disease

Martha Gulati,

Broadcast

Electrophysiology & Arrhythmia

COVID-19

POTS-associated Conditions and Management Strategies

Alexis Cutchins, Svetlana Blitshteyn, Rebecca Steinberg, et al

Watch time: 14s

Video

CV Disease in Special Populations

ACC.24: The PROACT Trial

David Austin,

Watch time: 3m 37s

Video

Heart Failure

Prevention & Chronic Conditions

ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi,

Watch time: 23m 6s

Broadcast

CV Disease in Special Populations

Practical Cardiovascular Principles of Cancer Survivorship

Daniel Lenihan, ,

Watch time: 1h 1m 32s

Masterclass on The Global Burden of CV Disease in Women

Video

Demographic

Standards & Guidelines

Masterclass on The Global Burden of CV Disease in Women

Birgit Vogel, Harriette Van Spall,

Watch time: 20m 32s

Video

Anticoagulation

Vascular Disease and Surgery

ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s

Broadcast

CV Disease in Special Populations

Ibrutinib Is Associated With Increased Cardiovascular Events and Major…

Daniel Lenihan, , , et al

Watch time: 53m 54s

Video Series

Anticoagulation

Standards & Guidelines

ESC 22: Late-breaking Science Collection

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Video Series

Demographic

Electrophysiology & Arrhythmia

Cardio-oncology A-Z

Neha Bansal, Joshua Mitchell, Avirup Guha, et al

Watch time: 56m 19s (7 videos)

Cardio-oncology A-Z: Breast Cancer Treatment Related Cardiotoxicity With Dr Anne Blaes

Video

Demographic

CV Disease in Special Populations

Cardio-oncology A-Z: Breast Cancer Treatment Related Cardiotoxicity

Watch time: 10m

Broadcast

CV Disease in Special Populations

Addressing Disparities in Cardio-Oncology

Daniel Lenihan, , , et al

Watch time: 58m 27s

Articles

The Role of Myocardial Perfusion Imaging in the Clinical Evaluation of CAD

Citation:

US Cardiology 2006;3(2):68–72

DOI:

https://doi.org/10.15420/usc.2006.3.2.68

Abstract
Full text
Login or register to view PDF.
Permissions
References

Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

Views: 737
Downloads: 5